Topic

Fiona Huzarski is Vice President of Global HR at ADVANZ PHARMA.

Articles

Fiona Huzarski outlines four lessons that pharma HR departments can learn from the coronavirus pandemic.

Recruitment Lessons from COVID-19

Dr. George Westerman talks to Michael Wong about how smarter executives will successfully lead their workforces in a post Covid-19 business environment.

Planning Ahead for a Post Covid-19 Workforce and Workplace

Jill Wechsler is Pharm Exec's Washington Corespondent

With all eyes on efforts to research and test potential vaccines and therapies to combat the coronavirus pandemic, fears about overly accelerated development programs has heightened demands for wider access to information on study protocols, statistical analysis plans, and early results.

COVID-19 Vaccine Concerns Prompt Clinical Trial Transparency

Elaine Quilici is Pharmaceutical Executive's Senior Editor. Email her at equilici@mmh.com

COVID Causes Pharma Marketers to Watch TV

Staying the Course in Product Launch

Assessing COVID-19’s wide and varied impact on pharma and biotech business in the first half of the year, and how it shapes market prospects ahead.

Taking Biopharma’s Pulse in a Tough 2020

Sheila Thorne is the President/CEO, Multicultural Healthcare Marketing Group, LLC, and is one of the nation's leading experts in multicultural healthcare marketing. For more information logo onto www.sheilathorne.com

Multicultural campaigns crafted for diverse populations are insufficiently funded and do not receive the same support as mainstream campaigns, writes Sheila Thorne. While there are plenty of people willing to partner with pharma on these campaigns, will the industry wake up to the changing world ahead?

The Cultural Deficit in the Pharma Industry in the Era of COVID-19

Filippo Petti is CEO of Celyad Oncology tells Pharm Exec how the pandemic has affected his role as a US-based CEO to a Belgian company.

Leading On Two Continents through COVID-19: Filippo Petti, Celyad Oncology

With nearly 25 years of experience in driving strategy & commercialization efforts in Biotech & Pharma, with an exclusive focus in Life Sciences (LS) strategic planning and industry marketing efforts for enterprise software solutions, Ferdi Steinmann is responsible for the LS global industry strategy development at 

Ferdi Steinmann outlines a few supply chain lessons that all pharma companies can learn from the COVID-19 pandemic.

The Pharma Supply Chain Post-COVID-19: Key Lessons and Opportunities 

A look at how pharmaceutical company, Paratek is navigating the launch of a new antibiotic during the COVID-19 pandemic.